Skip to main content
. 2015 May;100(5):633–642. doi: 10.3324/haematol.2014.117457

Figure 2.

Figure 2.

Actuarial risk of progression and survival of clonal or malignant myeloid transformation (CMMT) among the various categories of inherited bone marrow failure syndromes. (A) Fanconi anemia (FA), (B) Shwachman-Diamond syndrome (SDS), (C) Kostmann/severe congenital neutropenia (K/SCN), (D) Unclassified-IBMFS (UC-IBMFS). (E) Comparative analysis between FA, SDS and UC-IBMFS. The figures represent risk with 95% confidence intervals. (F) Fanconi anemia (FA), (G) Shwachman-Diamond syndrome (SDS), (C) Kostmann/severe congenital neutropenia (K/SCN), (H) Unclassified-IBMFS (UC-IBMFS), (I) Comparative analysis between FA, SDS, UC-IBMFS all groups with more than three patients with CMMT, (J) Comparative analysis of three categories (without K/SCN). The figures represent risk with 95% confidence intervals.